Diese Website verwendet Cookies, um Ihre Benutzererfahrung zu verbessern. Durch die weitere Nutzung der Website stimmen Sie der Verwendung von Cookies zu. Weiterlesen.
Ich nehme an
Archiv
Alle
Alle
Regulatorisch
Nicht-regulatorisch
2022-07-07
Non-regulatory
NeoDynamics receives ethical approval for German device registry
Weiterlesen
2022-06-17
Non-regulatory
Gryningskust Holding AB increases ownership in NeoDynamics
Weiterlesen
2022-06-09
Non-regulatory
Update on the FDA approval process for NeoNavia®
Weiterlesen
2022-05-24
Regulatory
Communiqué from the annual general meeting in NeoDynamics AB (publ)
Weiterlesen
2022-05-18
Non-regulatory
NeoDynamics Newsletter, May 2022
Weiterlesen
2022-05-17
Regulatory
New data from NeoDynamics’ PULSE study presented at major US breast imaging conference
Weiterlesen
2022-05-12
Regulatory
NeoDynamics AB (publ) first quarter 2022
Weiterlesen
2022-05-02
Non-regulatory
Trading in NeoDynamics shares on Nasdaq First North starts today
Weiterlesen
2022-04-28
Regulatory
NeoDynamics publishes supplementary document introducing listing on Nasdaq First North Growth Market
Weiterlesen
2022-04-27
Regulatory
NeoDynamics publishes Annual Report 2021
Weiterlesen
2022-04-26
Regulatory
Last day of trading in paid subscription shares (Sw.BTA)
Weiterlesen
2022-04-13
Regulatory
NeoDynamics conditionally approved for listing on Nasdaq First North
Weiterlesen
2022-03-28
Regulatory
NeoDynamics announces outcome of rights issue
Weiterlesen
2022-03-15
Non-regulatory
NeoDynamics sets up NeoDynamics USA Inc.
Weiterlesen
2022-03-01
Non-regulatory
NeoDynamics has filed for registration of NeoNavia® in the US
Weiterlesen
2022-02-25
Regulatory
Communique from extraordinary general meeting in NeoDynamics AB (publ)
Weiterlesen
2022-02-16
Non-regulatory
NeoDynamics to present Q4 report on Feb 21 at 12.30
Weiterlesen
2022-02-16
Regulatory
NeoDynamics AB (publ) full-year report 2021
Weiterlesen
2022-02-09
Regulatory
Notice of extraordinary general meeting in NeoDynamics AB
Weiterlesen
2022-01-24
Non-regulatory
Interview and company presentation in collaboration with Uddaaktier
Weiterlesen
2022-01-20
Non-regulatory
New data from NeoDynamics PULSE study accepted for presentation at major US breast imaging conference
Weiterlesen
2022-01-17
Non-regulatory
NeoDynamics to present at Redeye Fight Cancer Seminar 20 Jan 2022
Weiterlesen
2021-11-24
Non-regulatory
NeoDynamics appoints Aaron Wong as CFO
Weiterlesen
2021-11-17
Regulatory
Interim report Q3 2021
Weiterlesen
2021-11-15
Non-regulatory
NeoDynamics presents Q3 report
Weiterlesen
2021-11-08
Non-regulatory
NeoDynamics presents first results from PULSE study
Weiterlesen
2021-10-28
Non-regulatory
NeoDynamics starts subsidiary in Germany
Weiterlesen
2021-09-17
Non-regulatory
NeoDynamics confirms four orders for NeoNavia
Weiterlesen
2021-09-13
Non-regulatory
NeoDynamics demonstrates NeoNavia live at congresses
Weiterlesen
2021-08-25
Regulatory
NeoDynamics granted a U.S. patent for its biopsy needle
Weiterlesen
2021-08-19
Regulatory
Interim report Jan-June 2021
Weiterlesen
2021-07-09
Non-regulatory
NeoDynamics receives first German order of pulse biopsy system NeoNavia
Weiterlesen
2021-05-31
Non-regulatory
NeoDynamics presents at Redeye Growth Day 2021
Weiterlesen
2021-05-19
Regulatory
First quarter - Introduction underway
Weiterlesen
2021-05-17
Non-regulatory
NeoDynamics presents an abstract on pulse biopsy data for NeoNavia at the UK Association of Breast Surgeons Conference 2021
Weiterlesen
2021-04-27
Non-regulatory
Matthew E. Colpoys, Jr. nominated to the Board of Directors
Weiterlesen
2021-03-17
Non-regulatory
NeoDynamics presents preclinical results today
Weiterlesen
2021-03-15
Non-regulatory
Invitation - NeoDynamics presents preclinical results on March 17 at 13.00 CET
Weiterlesen
2021-02-17
Regulatory
NeoDynamics AB (publ) Full year report 2020
Weiterlesen
2021-01-14
Non-regulatory
NeoDynamics will be granted another European patent for its pulse biopsy tools
Weiterlesen
2020-11-19
Regulatory
NeoDynamics AB (publ) Third Quarter 2020
Weiterlesen
2020-11-19
Regulatory
NeoDynamics receives first UK order of pulse biopsy system NeoNavia
Weiterlesen
2020-11-12
Non-regulatory
NeoDynamics enters a scientific partnership to evaluate its technology platform in osteoarthritis
Weiterlesen
2020-11-02
Regulatory
Jörgen Vrenning is retiring as CFO of NeoDynamics
Weiterlesen
2020-10-21
Regulatory
NeoDynamics carries out directed new share issue of approximately SEK 90 million and convenes extraordinary general meeting
Weiterlesen
2020-10-21
Regulatory
NeoDynamics announces intention to carry out a directed share issue of approximately 24 million shares and intention to call for Extraordinary General Meeting
Weiterlesen
2020-09-25
Non-regulatory
NeoDynamics is approaching launch of new pulse biopsy system NeoNavia - reputed international gynecologists and radiologists gained positive hands-on experience
Weiterlesen
2020-08-21
Regulatory
NeoDynamics AB (publ) Half year report 2020
Weiterlesen
2020-07-06
Regulatory
NeoDynamics establishes reference centres in Germany to support the introduction of its novel pulse biopsy system NeoNavia and optimize the diagnosis of breast cancer
Weiterlesen
2020-07-06
Regulatory
NeoDynamics restarts patient recruitment to UK COMPULSE Study to optimize diagnosis of breast cancer
Weiterlesen
2020-05-26
Regulatory
NeoDynamics AB (publ) First Quarter 2020
Weiterlesen
2020-02-05
Regulatory
NeoDynamics AB (publ) full-year report 2019
Weiterlesen
2020-02-03
Non-regulatory
A clinical study performed at Karolinska Hospital with NeoDynamics’ new biopsy system, NeoNavia, has been accepted as an abstract by the Society for Breast Imaging (SBI) in the US.
Weiterlesen
2020-01-28
Non-regulatory
NeoDynamics AB (publ) receives notification of granted patent on biopsy instrument in China
Weiterlesen
2019-11-27
Non-regulatory
NeoDynamics signs manufacturing agreement for NeoNavia
Weiterlesen
2019-11-21
Regulatory
NeoDynamics AB (publ) Third quarter Jul-Sep 2019
Weiterlesen
2019-11-05
Non-regulatory
For the first time in UK, a wider audience can get first-hand experience of the NeoNavia® micropulse biopsy system for breast cancer
Weiterlesen
2019-10-29
Regulatory
NeoDynamics receives regulatory approval for new breast cancer biopsy system
Weiterlesen
2019-09-16
Non-regulatory
NeoDynamics recruits a country manager for Germany, Switzerland and Austria
Weiterlesen
2019-08-28
Regulatory
NeoDynamics has secured financing through the issue of convertibles and calls for an Extraordinary General Meeting
Weiterlesen
2019-08-28
Regulatory
NeoDynamics Half-year report 2019
Weiterlesen
2019-08-15
Non-regulatory
New date for NeoDynamics semi-annual report 2019
Weiterlesen
2019-05-22
Regulatory
NeoDynamics AB (publ) invests in biopsy instrument for more effective sampling of suspected skin cancer
Weiterlesen
2019-05-21
Regulatory
NeoDynamics AB (publ) - Quarterly report January-March 2019
Weiterlesen
2019-04-26
Regulatory
NeoDynamics AB (publ) receives advance notice from U.S. Patent Office for a granted biopsy instrument patent
Weiterlesen
2019-04-10
Non-regulatory
New breast biopsy device is evaluated at Karolinska University Hospital in Stockholm
Weiterlesen
2019-02-21
Regulatory
Year-end report 2018 - NeoDynamics
Weiterlesen
2019-02-18
Non-regulatory
New Swedish technology for breast cancer diagnosis tested by leading experts in Germany
Weiterlesen
2018-12-07
Non-regulatory
NeoNavia commercial version fully integrated according to plan
Weiterlesen
2018-12-07
Non-regulatory
First day of trading in NeoDynamics’ shares and warrants on Spotlight Stock Market
Weiterlesen
2018-11-19
Regulatory
NeoDynamics’ issue of units prior to planned listing on Spotlight Stock Market fully subscribed
Weiterlesen
2018-11-12
Non-regulatory
NeoDynamics participates on Stora Aktiedagen and in a Live Session with Småbolagsjakten today
Weiterlesen
2018-11-06
Non-regulatory
NeoDynamics participates in investor meetings during the IPO
Weiterlesen
2018-11-06
Non-regulatory
NeoDynamics introduces NeoNavia®, a micropulse biopsy system, to a wider audience in the UK
Weiterlesen
2018-11-01
Non-regulatory
New technology from NeoDynamics approved for study in Germany
Weiterlesen
2018-10-31
Regulatory
The subscription period in NeoDynamics’ issue of units prior to planned listing on Spotlight Stock Market begins today
Weiterlesen
2018-10-30
Regulatory
NeoDynamics AB (publ) announces approval on passportation of prospectus
Weiterlesen
2018-10-29
Regulatory
NeoDynamics AB (publ) publishes prospectus and enters agreement on additional subscription commitment
Weiterlesen
2018-10-25
Regulatory
NeoDynamics AB (publ) approved for listing on Spotlight Stock Market
Weiterlesen